Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — 1H 2015 Earnings Presentation

8 slides from Novonesis A/s Class B's earnings presentation, Aug 6, 2015

  1. Slide 1: Conference call 1H 2015

    Conference call 1H 2015 ​August 6, 2015

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements ​This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "be

  3. Slide 3: 1H 2015 Summary

    1H 2015 Summary ​Strong earnings performance despite headwinds in Sales and organic growth 1H 2013 – 1H 2015 important markets DKKm 10% 8% 8,000 • 5% organic sales growth is below expectations. 15% growth in DKK sales – highest-ever reported sales in six months 8% 6% 7,000 6% 7,028 • Strong growth i

  4. Slide 4: Sales growth slowed in Bioenergy

    Sales growth slowed in Bioenergy ​1H sales up by 2% organically U.S. semi-annual ethanol volume growth rates and Novozymes Bioenergy organic sales growth 1. Challenging market dynamics: U.S. ethanol volume growth Novozymes org. Bioenergy growth Volatile commodity prices and 35% low ethanol margins h

  5. Slide 5: Sales & Markets

    Sales & Markets ​1H 2015 sales: DKK +15%, organic +5% Sales by industry, DKKm DKK growth org. growth ​Q2 2015 sales: DKK +13%, organic +1% Household 2,265 Household Care: Sales negatively impacted by uncertainty in Care 2,124 +7% / 0% emerging markets, a dynamic U.S. market and lower sales to one cu

  6. Slide 6: R&D Update

    R&D Update • Household Care: Working on new innovation for stain removal, hygiene improvement and dedicated emerging markets solutions to accelerate growth • Bioenergy: Expect to launch one or more innovations during 2H 2015 to address changing demands from U.S. corn ethanol producers • Animal Healt

  7. Slide 7: 1H 2015 Financial Performance & Outlook

    1H 2015 Financial Performance & Outlook ​Strong earnings performance in 1H 2015 Key Realized 2015 Outlook 2015 Outlook • Gross margin slightly up financials 1H 2015 Aug. 6 Apr. 23 • Disregarding the net one-time impact from The BioAg Alliance, Sales growth, org. +5% 4-7% 7-9% EBIT grew by ~20%, main

  8. Slide 8: Novozymes Rethink Tomorrow

    x novozymes’ Rethink Tomorrow

Novozymes — 1H 2015 Earnings Presentation on 6ix